Navigation Links
Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates
Date:12/22/2009

LONDON, ON, Dec. 22 /PRNewswire/ - Viron Therapeutics Inc., a biotechnology company pioneering the development of virally-derived protein therapeutics, today announced that it has been granted U.S. patents related to three of its drug candidates, VT-111, VT-346 and VT-384. These patents join a portfolio of more than 80 previously-granted patents for Viron's multiple therapeutic candidates. Viron's unique drug discovery platform identifies proteins expressed by non-human viruses that have evolved over millions of years of evolutionary selection to evade their host's immune system, endowing them with powerful immuno-modulatory and anti-inflammatory properties.

The new patent, US 7,514,405, entitled "Methods for treating transplant rejection," covers the treatment of chronic transplant rejection by administering VT-111 in combination with an immunosuppressant, such as cyclosporine. "This patent extends protection for VT-111 in transplant out to at least 2021," said Kevin Sullivan, Vice President of Business Development for Viron Therapeutics. "This provides ample time for us to unlock the commercial potential arising from upcoming organ transplant trials." Viron will pursue the transplant indication in parallel with Acute Coronary Syndromes (ACS) for VT-111, due to the significant unmet medical need in this space and the resulting rapid regulatory path forward. There are currently no therapeutic molecules targeting chronic organ rejection.

Viron's lead therapeutic candidate, VT-111, has demonstrated potent effects in preclinical suppression of chronic organ transplant rejection and, in a Phase IIa clinical trial of 48 patients, demonstrated reduced cardiac tissue damage in patients with ACS receiving cardiac stent implants. "It is remarkable to see such a small trial demonstrate such a strong, statistically significant impact in this target population," said Mr. Sullivan. "These trial results provide a compelling validation of Viron
'/>"/>

SOURCE Viron Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
2. Landfill mining reduces environmental impact of growing waste
3. Landfill mining reduces environmental impact of growing waste
4. Nanowire generates power by harvesting energy from the environment
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Environmental Tectonics Corporations BioMedical Division Announces New Contract
7. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
8. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
9. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
10. Nanotechs health, environmental impacts worry scientists and the public
11. Fixed C-Arms Revolutionize Operating Room Environments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Hungary , September 30, 2014 ... and intuitive browsing of chemistry in documents ... chemistry software solutions and consulting services for life ... chemical information and generate Markush structures from documents. ... an organizations intellectual property, however generating and understanding ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014 FemCap ... women,s health announces its receipt of a patent No: ... menstrual cup has also received FDA clearance in the ... and the CE in Europe. This patent is related to ... with this issuance, the company is releasing FemmyCycle Teen, ...
(Date:9/30/2014)... Boston, MA (PRWEB) September 30, 2014 ... communications (UC) and collaboration company is dedicated to ... data connectivity needs. Julie Power, a ... team to ensure collaboration solutions stays connected and ... response to the increased movement of businesses to ...
(Date:9/30/2014)... September 30, 2014 Back in the 1970’s, ... square feet. per employee, which included space for circulation and ... says Jeff Howell, partner at Nidea Corporate Real Estate ... Toronto. “By the year 2000, however, 250 square feet ... that number come down to 175 to 225 square feet, ...
Breaking Biology Technology:ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2The FemmyCycle 2SoundConnect Expands Carrier Services Division 2ITRA Global Reports on How Companies Are Squeezing More Employees into Less Office Space 2ITRA Global Reports on How Companies Are Squeezing More Employees into Less Office Space 3
... 2011 AAPC ( www.aapc.com ) announced its ... again lowered prices from the previous year. Prices have been reduced ... primary purpose of a price reduction was to benefit our more ... the significant savings," said Olga Starynskaya, coding books department manager for ...
... Perceptive Informatics , the industry,s leading eClinical solutions provider ... PRXL ), today announced results of a global ... Response Adaptive Trials." The webinar, presented by Perceptive Informatics ... professionals from the biopharmaceutical industry across a broad range ...
... America, Inc . ( http://www.cordblood-america.com ) (OTC Bulletin Board: ... preservation company focused on bringing the life saving potential ... to announce that its shareholders have approved an amendment to ... The vote was approximately 80% for the stock ...
Cached Biology Technology:AAPC Lowers Prices on Medical Coding Books, Again 2Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 2Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 3Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 4Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs 5Cord Blood America: Shareholders Approve Common Stock Reverse Split 2
(Date:9/30/2014)... What do seedless watermelon, salmon, and strawberries all have ... have two sets of chromosomes and are diploid, these ... more sets of chromosomesseedless watermelon and salmon have 3 ... 10! While this might seem surprising, in fact ... was first discovered over a century ago, but only ...
(Date:9/30/2014)... Prenatal exposure to tetrachloroethylene (PCE) in drinking water ... abruption, according to a new study led by ... , The study, published in the journal ... 1,019 unexposed pregnancies among 1,766 women in Cape ... late 1960s to the early 1980s by the ...
(Date:9/30/2014)... involving mice and published in the October 2014 issue ... , suggests that just because you can do it, ... of Italian scientists have found that using marijuana in ... system. This damage may result in autoimmune diseases and ... disease and rheumatoid arthritis in adulthood. , "I hope ...
Breaking Biology News(10 mins):Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Contaminated water linked to pregnancy complications, BU study finds 2Adolescent exposure to thc may cause immune systems to go up in smoke 2
... a cold or flu knows, a high temperature is ... immune reaction when fighting off pathogens. Laboratory studies, in ... in detail, have shown that these responses display significant ... the maximum possible level of intensity? New immunological theories ...
... about positive and negative emotions they often use spatial metaphors. A ... person is down in the dumps. Some researchers believe these metaphors ... do we use spatial words to talk about emotional states, we ... and emotion To test this link between vertical space ...
... two license agreements with SuperPower, a wholly-owned subsidiary ... intellectual property on second generation (2G) high temperature ... Sponsored Research Agreement (SRA) previously executed between the ... by Venkat Selvamanickam, M.D. Anderson chair professor of ...
Cached Biology News:Only some like it hot 2To remember the good times, reach for the sky 2SuperPower and UH sign high temperature superconducting wire license agreements 2
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C...
Carrier-Free Recombinant Human Flt-3/Flk-2 Ligand (Flt3/Flk2 Ligand, Flt3L, Flt3-L, Flk2L, Flk2-L) 100 ug...
Anti-CD74 Monoclonal Antibody Description: 200 l Research Focus: cell surface antigens Storage: 4C Shipping Temperature: 4C...
POU domain, class 2, transcription factor 2,...
Biology Products: